Β-lactam allergy: Difference between revisions
From IDWiki
Β-lactam allergy
m (Aidan moved page Beta-lactam allergies to β-lactam allergy without leaving a redirect) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:β-lactam allergy}} |
|||
| ⚫ | |||
| ⚫ | |||
* Cross-reactivity between [[penicillins]] and [[cephalosporins]] is mediated by homology of the R1 side chains, referring to the C6 side chain in [[penicillins]] or the C7 side chain in [[cephalosporins]] |
|||
* Cross-reactivity within [[cephalosporins]] is mediated both by homology of the R1 side chains and also R2 side chains, referring to the C3 side chain |
|||
{| class="wikitable" |
{| class="wikitable" |
||
! rowspan="2" |Antibiotic |
! rowspan="2" |Antibiotic |
||
! colspan="3" align="center" | |
! colspan="3" align="center" |R1 |
||
! colspan="7" align="center" | |
! colspan="7" align="center" |R2 |
||
|- |
|- |
||
!G1 |
!G1 |
||
| Line 234: | Line 239: | ||
|} |
|} |
||
=== |
===R1 Side Chains (C6 and C7)=== |
||
*'''Group 1:''' [[penicillin]], [[cephalothin]], [[cefoxitin]] |
*'''Group 1:''' [[penicillin]], [[cephalothin]], [[cefoxitin]] |
||
| Line 240: | Line 245: | ||
*'''Group 3:''' [[cefipime]], [[cefotaxime]], [[ceftriaxone]] |
*'''Group 3:''' [[cefipime]], [[cefotaxime]], [[ceftriaxone]] |
||
=== |
===R2 Side Chains (C3)=== |
||
*'''Group 1:''' [[cefadroxil]], [[cephalexin]] |
*'''Group 1:''' [[cefadroxil]], [[cephalexin]] |
||
| Line 269: | Line 274: | ||
[[Category:Antibiotics]] |
[[Category:Antibiotics]] |
||
[[Category:Immunology]] |
|||
Revision as of 14:12, 16 September 2020
Cross-Reactivity
- Cross-reactivity between penicillins and cephalosporins is mediated by homology of the R1 side chains, referring to the C6 side chain in penicillins or the C7 side chain in cephalosporins
- Cross-reactivity within cephalosporins is mediated both by homology of the R1 side chains and also R2 side chains, referring to the C3 side chain
| Antibiotic | R1 | R2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| G1 | G2 | G3 | G1 | G2 | G3 | G4 | G5 | G6 | G7 | |
| Penicillin | X | |||||||||
| Ampicillin | X | |||||||||
| Amoxicillin | X | |||||||||
| Cefazolin | ||||||||||
| Cephalexin | X | X | ||||||||
| Cefadroxil | X | X | ||||||||
| Cephalothin | X | X | ||||||||
| Cefotetan | X | |||||||||
| Cefoxitin | X | X | ||||||||
| Cefuroxime | X | |||||||||
| Cefaclor | X | |||||||||
| Cefotaxime | X | X | ||||||||
| Ceftriaxone | X | |||||||||
| Ceftazidime | X | |||||||||
| Cefixime | X | |||||||||
| Cefdinir | ||||||||||
| Cefipime | X | |||||||||
| Ceftaroline | ||||||||||
R1 Side Chains (C6 and C7)
- Group 1: penicillin, cephalothin, cefoxitin
- Group 2: amoxicillin, ampicillin, cefaclor, cephalexin, cefadroxil
- Group 3: cefipime, cefotaxime, ceftriaxone
R2 Side Chains (C3)
- Group 1: cefadroxil, cephalexin
- Group 2: cefotetan
- Group 3: cefotaxime, cephalothin
- Group 4
- Group 5: cefuroxime, cefoxitin
- Group 6: cefixime
- Group 7: ceftazidime
Hypersensitivity Reactions
- Type I (IgE-mediated)
- Anaphylaxis
- Itchy rash
- Penicillins should be avoided
- Type II (IgG-mediated)
- Non-itchy rash
- Rash will improve if treatment continues, no need to avoid penicillins
- Type IV (cell-mediated)
- Toxic epidermal necrolysis
- Stevens-Johnson syndrome
- Penicillins should be avoided
Further Reading
- Zagursky RJ and Pichichero ME. Cross-reactivity in β-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72-81.e1. doi: 10.1016/j.jaip.2017.08.027
References
- ^ Brittany Kula, Gordana Djordjevic, Joan L. Robinson. A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins?. Clinical Infectious Diseases. 2014;59(8):1113-1122. doi:10.1093/cid/ciu587.
- ^ Anna R. Wolfson, Emily M. Huebner, Kimberly G. Blumenthal. Acute care beta-lactam allergy pathways: approaches and outcomes. Annals of Allergy, Asthma & Immunology. 2019;123(1):16-34. doi:10.1016/j.anai.2019.04.009.
